Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|December 25, 2009
[Cyclic imine toxin gymnodimine: a review]Ren-yan Liu, Yu-bo LiangWorld Journal of Gastroenterology|February 24, 2025
Mechanistic link between long noncoding RNA and stability of oncogene reveals stemness and chemoresistance of hepatocellular carcinomaYu-Bo Liang, Xing-Ming Chen, Wan-Ling Luo, et al.Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|December 15, 2025
Development of enzyme-linked immunosorbent assay with nanogold-labeled probes for detection of diarrhetic shellfish toxinsRui Zhao, Lei Han, Zhao Liu, et al.Ying Yong Sheng Tai Xue Bao = the Journal of Applied Ecology|June 11, 2011
[Self-pollution in Ruditapes philippinarum bottom-cultured area of Zhuanghe coast]Xiu-tang Yuan, Sheng-li Zhang, Shu-xi Liu, et al.World Journal of Gastroenterology|June 27, 2025
Activation of lymphangiogenesis by platelet as novel therapeutic approaches for liver cirrhosis and portal hypertensionJian-Fu Li, Qing-Bo Wang, Yu-Kai Li, et al.International Journal of Molecular Medicine|January 16, 2026
ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review)Xing-Ming Chen, Yu-Bo Liang, Jin-Xiang Zuo, et al.Frontiers in Immunology|October 7, 2024
Tumor-associated lymphatic vessel density is a reliable biomarker for prognosis of esophageal cancer after radical resection: a systemic review and meta-analysisJin Li, Qing-Bo Wang, Yu-Bo Liang, et al.Frontiers in Immunology|January 22, 2025
Tumor-associated lymphatic vessel density is a postoperative prognostic biomarker of hepatobiliary cancers: a systematic review and meta-analysisJin Li, Yu-Bo Liang, Qing-Bo Wang, et al.Journal of Hepatocellular Carcinoma|December 12, 2025
Impact of Middle Hepatic Vein Resection During Hemihepatectomy on Surgical Outcomes and Long-Term Prognosis in Hepatocellular Carcinoma: A Retrospective StudyWan-Ling Luo, Qing-Bo Wang, Yu-Kai Li, et al.Liver Cancer|December 18, 2025
Rechallenge with Immune Checkpoint Inhibitors in Patients with Hepatocellular Carcinoma: A Narrative ReviewJin Li, Yu-Bo Liang, Qing-Bo Wang, et al.Pageof 2